Fingerprint
Dive into the research topics of 'UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan
Leslie E. Carlini, Neal J. Meropol, John Bever, Michael L. Andria, Todd Hill, Philip Gold, Andre Rogatko, Hao Wang, Rebecca L. Blanchard
Research output: Contribution to journal › Article › peer-review
228
Scopus
citations